Cipro Unimed 250 mg, 500 mg, 750 mg FC tablets
PDF Leaflet Revision Date: 28 May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by ciprofloxacin sensitive bacteria.
Dosage (summary)
250 to 750 mg twice daily, depending on infection type.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential cartilage damage.
Key Drug Interactions
- Tizanidine
- Methotrexate
- Theophylline
- Vitamin K antagonists
Contraindications
- Hypersensitivity to ciprofloxacin
- Children under 18
- Myasthenia gravis
- Aortic aneurysm
Common side effects
- Nausea
- Diarrhoea
- Headache
- Dizziness
- Rash
Counselling Points
- Avoid direct sunlight
- Stay hydrated
- Monitor for signs of tendon pain
- Report any psychiatric symptoms
Serious warnings
- Risk of tendon rupture
- CNS effects including seizures
- QT prolongation
Important Disclaimer
The Cipro Unimed 250 mg, 500 mg, 750 mg FC tablets professional information leaflet below is the property of Unimed Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
